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Somatic Hypermutation in the Heavy Chain Locus
Correlates with Transcription
of somatic hypermutation within 2 kb downstream of
each promoter but not between these two areas (Peters
and Storb, 1996; Rada et al., 1997).
Yosho Fukita, Heinz Jacobs,*²
and Klaus Rajewsky
Institute for Genetics
University of Cologne In previous analyses of somatic hypermutation, con-
ventional transgenic mice have often been used. AnWeyertal 121
D-50931, Cologne inherent problem of conventional transgenesis is the
random integration of several copies of the transgeneGermany
into the genome (Lacy et al., 1983). In contrast, gene
targeting allows the targeted insertion of a single gene
copy into any given locus. We have used the latter ap-Summary
proach to study the dependence of somatic hypermuta-
tion in the IgH locus on transcription of the rearrangedThree mutant immunoglobulin heavy chain (IgH) inser-
VHDHJH element.tion mice were generated in which a targeted nonfunc-
For this purpose, we generated three IgH insertiontional IgH passenger transgene was either devoid of
mice that carry a rearranged VHDHJH gene segment thatpromoter (pD) or was placed under the transcriptional
either lacked a promoter (pD mice) or was placed undercontrol of either its own RNA polymerase II±dependent
the control of either the Ig heavy chain gene promoterIgH promoter (pII) or a RNA polymerase I±dependent
(pII mice) or an RNA polymerase I (pol I)±dependentpromoter (pI). While the transgene mutation-frequency
promoter (pI mice). The pol I±dependent promoter was(0.85%) in memory B cells of pI mice was reduced
chosen since it might allow one to distinguish betweencompared to that in pII mice (1.4%), the distribution
transcription per se and the coupling of a putative muta-and the base exchange pattern of point mutations
tor to a pol II±specific component. The analysis of so-were comparable. In pD mice, the mutation frequency
matic hypermutation in these IgH insertion mice is thewas drastically reduced (0.09%). The mutation fre-
subject of this report.quencies correlated with the levels of transgene-spe-
cific pre-mRNA expressed in germinal center B cells
isolated from the mutant mice. Results
Generation of Mutant Mice
Introduction Previously, a mutant mouse strain (designated B1-8i)
was generated in which the JH locus and the DQ52 ele-
Rearranged immunoglobulin (Ig) genes can be further ment were replaced by the VHDHJH segment of (4-hydroxy-
diversified by somatic hypermutation during T cell± 3-nitrophenyl) acetyl (NP)±binding antibody, B1-8 (So-
dependent immune responses (see Rajewsky, 1996, for noda et al., 1997). The targeting vector used for the
review). Somatic hypermutation occurs in germinal cen- generation of this B1-8i mouse was modified to con-
ters (GC) (Berek et al., 1991; Jacob et al., 1991), is char- struct three different targeting vectors for the experi-
acterized by an elevated frequency of mutations, and ments presented here (Figures 1A±1H). The vectors share
is restricted to the variable regions of Ig heavy and light a termination codon in the leader exon of the rearranged
chain genes (Kim et al., 1981; Gearhart and Bogenhagen, B1-8 VHDHJH (VHB1-8) gene, rendering the inserted trans-
1983; Lebecque and Gearhart, 1990; Weber et al., 1991). gene inert to selection pressures imposed on produc-
Analyses of Ig-transgenic mice have provided insights tively rearranged heavy chain genes. In this way, infor-
into the cis-acting DNA elements required to target so- mation on the intrinsic specificity of the hypermutation
matic mutation to the V(D)J region (O'Brien et al., 1987). process can be obtained (Sharpe et al., 1991; Betz et
In the case of the k light chain gene, the k intronic and al., 1993). The first vector contained the physiological
39 enhancers but not the rearranged VkJk segment itself promoter of the VHB1-8 gene. The resulting mutant mice
were found to be essential for hypermutation to occur served as positive controls for the analysis of somatic
(Betz et al., 1994; Yelamos et al., 1995). The V gene hypermutation of the inserted VHB1-8 gene. The second
promoter can be exchanged by other RNA polymerase vector was constructed such that the VH promoter up-
II (pol II)±dependent promoters without affecting hyper- stream of the VHB1-8 gene was deleted. Analysis of this
mutation (Betz et al., 1994; Tumas-Brundage and Manser, deletion mutant should reveal the relevance of the VH
1997). A linkage between transcription initiation and the promoter for somatic hypermutation. In the third vector,
occurrence of somatic hypermutation has been sug- the VH gene promoter was replaced by a bipartite 2.2
gested by Peters and Storb, who found that placing an kb pol I promoter fragment (Kuhn et al., 1990). These
additional Ig promoter immediately 59 to the constant targeting vectors were transfected individually into E14.1
portion of the Igk chain gene leads to the occurrence ES cells (KuÈ hn et al., 1991). Homologous recombinants
were identified by PCR screening and confirmed by
Southern blot analysis. Recombinant ES cell clones
*To whom correspondence should be addressed (e-mail: Jacobs
were then injected into C57B/6 blastocysts to generate@BII.CH).
chimeras, which transmitted the mutant genes through²Present address: Basel Institute for Immunology, Grenzacher-
strasse 487, CH-4005, Basel, Switzerland. the germline. Removal of the loxP-flanked neor gene in
Immunity
106
Figure 1. Targeted Insertion of the Modified
VHB1-8 Gene into the Germline of the IgH
Locus
(A) Partial restriction endonuclease map of
the wild-type IgH locus. The closed circle rep-
resents the IgH intronic enhancer, and closed
boxes represent DQ52 and JH1-4 elements.
B, BamHI; R, EcoRI; H, HindIII; P, PstI; probe
A, HindIII±XhoI fragment; probe B, NaeI±EcoRI
fragment; probe C, EcoRI±HindIII fragment.
(B) Targeting cassette vector (Sonoda et al.,
1997). This vector was used for the introduc-
tion of the modified B1-8 VHDHJH (VHB1-8)
gene mentioned below. The XhoI±EcoRI frag-
ment containing the DQ52 and JH1-4 ele-
ments was replaced by VHB1-8 and the floxed
neomycin gene. Closed triangles represent
the loxP sites.
(C, E, and G) Predicted structure of the tar-
geted IgH locus of the VH promoter (pII) mice
(C), the promoter deletion mice (E), and the
pol I promoter (pI) mice (G) before deletion of
the neomycin gene. Arrowheads indicate the
position of PCR primers. The fragment sizes
(in kilobases) detected by probes A, B, and
C are indicated.
(D, F, and H) Predicted structure of the tar-
geted IgH locus of the pII mice (D), the pD
mice (F), and the pI mice (H) after deletion of
the neomycin gene.
(I±K) Southern blot analysis of offspring of
germline chimera. (I and K) HindIII- and (J)
EcoRI-digested tail DNA from offspring of
germline chimera before and after deletion of
the neomycin gene was hybridized with probe
A (I), probe B (J), and probe C (K). Lanes 1,
wild-type 129 mouse; 2 and 3, the pII mice
before and after deletion of the neomycin
gene, respectively; 4 and 5, the pD mice be-
fore and after deletion of the neomycin gene,
respectively; 6 and 7, the pI mice before and
after deletion of the neomycin gene, respec-
tively. Fragment sizes (in kilobases) are indi-
cated.
the targeted locus was achieved by crossing the animals the cells were depleted of IgM1 B cells, T cells, and
macrophages using magnetic cell sorting (Miltenyi etto the deleter strain (Figures 1I±1K) (Schwenk et al., 1995).
al., 1990), and the remaining cells were subsequently
stained with IgM-, IgD-, Thy1-, CD11b-, CD45R-, andSomatic Hypermutation of VHB1-8 Depends
on the Presence of the Promoter Vl1-specific antibodies. Single memory B cells were
sorted from the IgM2, IgD2, Thy12, CD11b2 (FITC-nega-Spleen cells of heterozygous mutant mice were stained
as described in the Experimental Procedures. In brief, tive), CD45R1 (allophycocyanin, APC-positive), Vl11
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Table 1. Somatic Mutation Analysis of pD, pI, and pII Mice
PCR Products with
Point Mutation (#)/
Total PCR
Products Point mutations Actual Mutation Normalized Mutation
Mutant Strain Sequenced Mutation Frequencya per sequence (#) Frequencyb Frequencyc
pII mice (VHB1-8) 12/20 (60%) 0.84% (103/12200) 0±32 1.40% (103/7320) 100%
pD mice (VHB1-8) 8/35 (22%) 0.056% (12/21350) 0±3 0.24% (12/4880)
[0.092% (12/12200)]d 6.5%e
pD mice (Vl1) 20/35 (57%) 0.60% (51/8400) 0±7 1.06% (51/4800)
pI mice (VHB1±8) 14/25 (56%) 0.47% (73/15250) 0±17 0.85% (73/8540) 60%
Naive B cells from 2/20 (10%) 0.030% (3/12200) 0±2
Pol II mice
a Mutation frequency 5
Total numbr of point mutations
Total number of base pairs sequenced
b Actual mutation frequency 5
Total number of point mutations
Total number of base pairs of PCR products containing point mutations
c Actual mutation frequency of the pII mice was normalized as 100%, and actual mutation frequency of the pD mice and pI mice were compared.
d This number was calculated based on the finding that 57% of memory B cells of the pD mice were under the influence of a putative somatic
hypermutation machinery, but due to a lack of promoter activity the actual point mutation process failed to occur.
e This number was calculated based ond.
(phycoerythrin, PE-positive) fraction. The VHB1-8 gene genes amplified from single cells of the same B cell
fraction in wild-type mice are mutated (Jacobs et al.,was amplified from the genomic DNA of these single
cells, using primers that specifically hybridize to the 1998). The mutation frequency is 0.84% (103 mutations/
12200 nt [610 nt 3 20 samples]) in the VHB1-8 passengercorresponding sequences of the inserted VHB1-8 gene
of the targeted allele and not to the endogenous VHB1-8 transgene of pII mice. Taking only the mutated VHB1-8
genes into account, the mutation frequency is 1.4% (103gene. PCR products were purified from agarose gels and
directly sequenced. Coamplification and sequencing of mutations/7320 nt [610 nt 3 12 samples]). The number
of point mutations found in the amplificates of memorythe functionally rearranged Vl1 gene (Ford et al., 1994;
Gonzalez-Fernandez et al., 1994) served as an internal B cells varied from 0 to 32 (Figure 2).
When analyzing somatic hypermutation in memory Bcontrol for the mutator activity. At least two independent
experiments were performed for each mutant strain. cells derived from pD mice, the percentage of mutated
VHB1-8 genes was reduced to 22%, compared to 60%The PCR error frequency of our experimental setup
was controlled by sequencing the VHB1-8 amplificates found in pII mice (Table 1). In addition, the maximum
number of point mutations detected in a mutated genefrom 20 naive (IgM1, IgD1, CD45R1, and Vl11) B cells
derived from pII mice. Two PCR products were found was 3, as compared to 32 in pII mice. To verify that we
had indeed isolated memory B cells, we coamplifiedto have one and two point mutations, respectively. The
Taq polymerase error frequency was 0.03% (3 muta- and sequenced the Vl1 genes from the same single
cells. 57% of the Vl1 genes were found to be mutated,tions/12200 nt).
As expected, somatic hypermutation of the VHB1-8 a value comparable to the percentage of mutated Vl1
genes in memory B cells of wild-type mice and mutatedgene occurred normally in pII mice. About 60% of the
sequenced samples contained multiple point mutations VHB1-8 genes in memory B cells of pII mice (Table 1).
Therefore, although only 22% of the analyzed VHB1-8(Table 1), consistent with the finding that 64% of Vl1
Figure 2. The Percentage of VHB1-8 Genes
with a Given Number of Point Mutations from
pD, pI, and pII Mice
Total number of mutations found were 12 in
the pD mice, 73 in the pI mice, and 103 in the
pII mice.
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Table 2. Base Exchange Pattern of Hypermutation
pII pI pD
n 5 103
to
n 5 72
to
n 5 12
to
A G C T % A G C T % A G C T %
A
ÐÐÐÐÐÐÐÐÐÐÐÐÐÐÐ
7 11 14 31 A
ÐÐÐÐÐÐÐÐÐÐÐÐÐÐÐ
13 0 6 27 A
ÐÐÐÐÐÐÐÐÐÐÐÐÐÐÐ
1 1 1 25
G 15 10 4 28 G 14 6 4 33 G 1 0 0 8
fr
o
m
3 9 14 25 fr
o
m
4 4 8 22 fr
o
m
1 0 6 59C C C
T 5 6 5 16 T 3 2 8 18 T 1 0 0 8
genes were mutated, the analysis of the Vl1 genes from and pI mice, notably at position 31II, 65II, and 105II of the
VHB1-8 gene (numbering according to Kabat and Wu,the same single cells indicated that hypermutation actu-
ally occurred in 57% of the samples. Taking this finding 1991). These codons are typical hot spots with a RGYW
consensus motif (where R is a purine base [A or G], Yinto account, the mutation frequency of the pD VHB1-8
gene further decreases from 0.24% (based on 22% mu- a pyrimidine base [C or T], and W is A or T). This motif
is a salient feature of major hot spots (Rogozin andtated VH genes) to 0.09% (based on 57% mutated Vl1
genes). Thus, the frequency of VHB1-8 mutations in Kolchanov, 1992). In line with previous results (Betz et
al., 1993), these hot spots reflect intrinsic properties ofmemory B cells of pD mice is 15-fold lower than in
memory B cells of pII mice. In contrast, the mutation the molecular mechanism of somatic hypermutation.
As for the base exchange pattern, A and G nucleotidesfrequency of 1.1% at the l locus is consistent with a
previous analysis (Jacobs et al., 1998), indicating that change to another nucleotide more frequently than C
and T in both the pII mice and the pI mice (Table 2).the hypermutator as such is unaffected in memory B
cells of pD mice. As so far only 12 point mutations were These base substitution preferences are comparable to
those seen in other passenger genes (Betz et al., 1993).found in the pD mice, the relevance of the frequent
C nucleotide changes (7/12) remains unclear (Table 2).
These results demonstrate the importance of the VH Transcription of Mutant VHB1-8 Genes in GC
B Cells of pI, pII, and pD Micepromoter in the process of somatic hypermutation.
To explore a possible relation between somatic hyper-
mutation and transcriptional activity at the IgH locus,Can the Pol I Promoter Substitute the Pol II
Promoter in the Control of we determined the pre-mRNA and mRNA levels of the
mutant B1-8 transgenes in GC-derived B cells by com-Somatic Hypermutation?
To answer this question, somatic hypermutation was parative RT-PCR (Klein et al., 1997). Using random hex-
amers, cDNA libraries were synthesized from total RNAanalyzed in single memory B cells isolated from pI mice.
Similar to the percentage of mutated VHB1-8 genes in isolated from 1 3 105 CD45R1 PNAhigh B cells from each
of the mutant mice. Two sets of oligonucleotides werepII mice and mutated Vl1 chain genes in pD mice, 56%
of the amplificates were mutated (Table 1). However, designed such that they specifically primed the mutant
VHB1-8 and the b-actin cDNAs, respectively. In boththe range of mutations per gene (0±17) was below that
of pII mice (0±32). Similarly, the mutation frequency in cases, the conditions for the amplification were chosen
such that the accumulation of products was in the ex-memory B cells of pI mice was reduced to 0.84%, i.e.,
60% of the level found in pII mice (Table I). As indicated ponential phase. PCR products were gel-fractionated,
blotted onto a nylon-membrane, and hybridized within Figure 3, thepol Ipromoter did not have any significant
impact on the distribution of point mutations compared a32P-labeledVHB1-8 or b-actin probes. The 322 bp ampli-
ficates of the b-actin cDNA served as an internal stan-to pol II promoter-controlled hypermutation.
Identical hot spots were found in VHB1-8 genes of pII dard to normalize the expression level of the VHB1-8
Figure 3. Location of Somatic Hypermuta-
tion in the Modified VHB1-8 Gene in pD, pI,
and pII Mice
The point mutations found in the VHB1-8 gene
of memory B cells are given as percentage
of mutations per codons sequenced and are
plotted against the position of the VHB1-8
gene (numbering according to Kabat and Wu,
1991; point mutations in the leader intron and
JH2 intron are also given). Percentages were
calculated from eight mutated sequences of
pD mice, 14 of pI mice, and 12 of pII mice.
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Table 3. Relative VHB1-8 mRNA Levels in PNAhigh B Cells
pII Mice pD Mice pI Mice
Pre-mRNA 100% 8% 72%
mRNA 100% 23% 87%
All the data were first normalized to b-actin expression. For both
pre-mRNA and mRNA, the amount of PCR products of the pD mice
and the pI mice was normalized against the PCR products of the
pII mice.
1993; Lozano et al., 1994; Peltz et al., 1994; Maquat,
1995; Aoufouchi et al., 1996).
The Level of Mutant VHB1-8-Specific Pre-mRNA
Correlates with the Frequency
of Somatic Hypermutation
To compare the pre-mRNA levels with the frequency
of somatic hypermutation, we normalized the values
obtained from pII mice to 100%. The pre-mRNA rather
than the mRNA level was chosen, since the pre-mRNA
level should relate more directly to the transcription rate
(Zhang et al., 1994). The resulting relative mutation fre-
quencies of the pD mice and the pI mice were 7% and
Figure 4. Comparative PCR of cDNAs Generated from Splenic 60%, respectively (Table 1). These figures correlate
B2201PNAhigh B Cells from pD, pI, and pII Mice
roughly with the relative amounts of pre-mRNA: 8% and
(A) Schematic figure illustrating the PCR approach to amplify the
72% in the pD mice and pI mice, respectively (Table 3).cDNA species from the mRNA and pre-mRNA of the VHB1-8 genes.
Boxes indicate the leader exon and VHDHJH exon of the inserted
VHB1-8 gene. Arrows indicate the location of primers used for the VHB1-8 Transcripts in pI Mice are Polyadenylated
amplification of VHB1-8 cDNA. The thick lines labeled with 265 bp In contrast to RNA pol II transcripts that are synthesized
and 183 bp represent the coding sequence of the pre-mRNA and
in the nucleoplasm, pol I transcripts of the ribosomalmRNA, respectively. The thin line indicates the leader intron.
genes are synthesized in the nucleolus and are neither(B) Southern blot analysis of amplified cDNA corresponding to
capped nor polyadenylated (Smale and Tjian, 1985). InVHB1-8 genes from the mutant mice. Experiments were performed
in duplicate. The upper band corresponds to pre-mRNA of VHB1-8 the comparative RT-PCR experiment mentioned above,
genes and the lower band to mRNA of VHB1-8 genes. The sizes of a random hexamer-primed cDNA was used as a tem-
the bands are indicated. plate. To analyze whether VHB1-8 transcripts from the(C) Southern blot analysis of cDNA corresponding to the b-actin
pI mice are polyadenylated, the same comparative RT-gene transcripts from the mutant mice. In (B) and (C), 5,000 cell
PCR was performed using oligo(dT)-primed cDNA asequivalents of cDNA mixture were amplified in separate reaction
template. The level of VHB1-8 transcripts in this prepara-with VHB1-8 and b-actin primers.
tion was comparable to that in the random hexamer-
primed cDNA, indicating that the B1-8 transcripts from
the pI mice are polyadenylated (data not shown).
product. For the VHB1-8 cDNA, two PCR products of
different size were observed in all three mutant strains Discussion
(Figure 4A). As confirmed by sequencing, the 265 bp
fragment corresponded to the pre-mRNA of VHB1-8 and Gene Targeting Approach for the Analysis
the 183 bp fragment to the mRNA, lacking the 82 bp of Somatic Hypermutation
leader intron of VHB1-8 (Figure 4B). The ratio between To analyze the role of Ig transcription on somatic hyper-
the 265 and 183 bp fragments was similar in all samples. mutation of rearranged Ig genes, three different mutant
This argues against possible contamination of the sam- IgH insertion strains were generated. The gene targeting
ples by genomic DNA, as this would have favored the approach ensures a site-specific insertion of a single
amplification of the 265 bp fragment only. copy into the targeted allele and excludes random inte-
Normalization of the intensity of each band of the pD gration of several copies into the genome. The latter
mice and the pI mice against the corresponding bands are inherent problems of conventional transgenesis into
of pII mice revealed that the level of pre-mRNA was oocytes (Lacy et al., 1983).
8% and 72% and the level of mRNA 23% and 87%, The cis-acting elements that control somatic hyper-
respectively (Table 3).As splicing of pre-mRNA is usually mutation at the IgH locus are not completely defined.
an efficient process and occurs rapidly after transcrip- However, somatic hypermutation occurs normally in a
tion (Zhang et al., 1994), the relatively high ratio of pre- rearranged VHDHJH gene when targeted into its physio-
mRNA versus mRNA levels in this study is surprising logical position in the heavy chain locus (Taki et al.,
but may be due to the premature termination codon 1993). Consistent with these results, somatic hypermu-
tation of the B1-8 passenger transgene in the IgH locusinserted into the VHB1-8 transgene (Cheng and Maquat,
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occurred normally with respect to frequency and distri- frequency was 60% of that found in memory B cells of
pII mice. To date, promoter exchange experiments havebution of point mutations, and base exchange pattern.
About 60% of the IgH passenger transgenes amplified analyzed somatic hypermutation of Ig genes under the
control of the human b globin promoter (Betz et al.,from single class switched Vl11 memory B cells were
mutated, a value that is reproducibly found in Vl1 genes 1994) and the mouse B29 promoter (Tumas-Brundage
and Manser, 1997). Both promoters are pol II±dependent,amplified from class switched Vl11 B cells of wild-type
and other mutant mouse strains (Jacobs et al., 1998). the enzyme known to control the synthesis of all precur-
sor messenger RNA (pre-mRNA) inmammalian cells (Za-The possibility that the unmutated amplificates are due
to a contamination with naive Igm1l11 B cells is unlikely, wel and Reinberg, 1992; Zawel et al., 1995; Orphanides
et al., 1996). In contrast, the pol I promoter controlssince the sorted cells expressed high levels of the Vl1
light chain at their surface and stained negative for IgM- the synthesis of the ribosomal RNA precursor in the
nucleolus, which subsequently is processed into the 28S,and IgD-specific MAb. Therefore, z40% of class switched
Vl11 B cells likely carry unmutated VlJl or VHDHJH gene 18S,and 5S ribosomal RNA (rRNA) species (Reeder, 1990).
In analogy to pol II promoters, the pol I promoter hassegment.
Compared to thepII mice, the mutation frequency was a bipartite organization, an upstream control element
(UCE), and a start site proximal core (Grummt and Skin-decreased 15-fold in the promoter-deficient passenger
transgene amplified from class switched Vl11 B cells ner, 1985; Smale and Tjian, 1985). The UCE contains 13
repeats of a 140-bp element, which enhances the activ-isolated from pD mice (Table 1). However, this lower
mutation frequency was clearly above the Taq polymer- ity of the pol I promoter (Kuhn et al., 1990). Exchanging
UCE by pol II transactivator sequences such as GAL4ase error, as determined for our experimental setup. In
addition, the point mutations found are not compatible DNA binding sites, E2 protein recognition sequences,
or an octamer motif, did not allow transcription from thewith the most frequent errors introduced by the Taq
polymerase, i.e., T to C or A to G exchanges (Tindall core pol I promoter (Schreck et al., 1989), suggesting
that the transactivation mechanism of pol I promoter-and Kunkel, 1988; Keohavong and Thilly, 1989). The 15-
fold decrease in the mutation frequency of the VHB1-8 controlled genes is different from that of pol II promoter-
controlled genes. However, when placing both elementsgene in pD mice compared to pII mice is strikingly similar
to the 12.5-fold decreased frequency of somatic hyper- of the bipartite pol I promoter upstream of the VHB1-8
gene, a high level of polyadenylated unspliced pre-mutation in DHJH rearrangements (0.2%) in comparison
to functional VHDHJH joints in hybridoma cells (2.5%) mRNA and spliced mRNA was found inGC B cells. These
observations suggest that either the pol II transcription(Roes et al., 1989).
Although the VH promoter of the VHB1-8 gene was machinery can transcribe a pol I promoter-controlled
heavy chain gene in the nucleoplasm, or the primarydeleted in the pD mice, a noticeable level of passenger
transgene-specific transcripts was found in the PNAhigh transcripts are indeed synthesized by the pol I transcrip-
tion machinery, and the altered subnuclear localizationB cells sorted from these mice. In all targeting experi-
ments, the downstream portion of the DQ52 promoter of the polymerase I transcripts (nucleoplasm instead
of nucleolus) allows the described posttranscriptional(Alessandrini and Desiderio, 1991; Kottmann et al., 1992,
1994), the DQ52 element, and the JH locus were replaced modifications. Since we cannot exclude either possibil-
ity, the question whether the putative mutator is physi-by the modified VHB1-8 gene. Early in B cell develop-
ment, the DQ52 promoter appears to be necessary to cally associated with the RNA polymerase II complex,
or the level of transcription just reflects the accessibilitygenerate full accessibility for the V(D)J recombination
machinery (Thompson et al., 1995). According to in vitro of the putative mutator to the IgH locus, remains unan-
swered.studies on the DQ52 promoter (Kottmann et al., 1994),
the truncated form of the DQ52 promoter as present in
the targeted alleles is transcriptionally inactive. The next
Somatic Hypermutation Correlates with Transcriptionnearest identified D segment is Dsp2, which locates 17
In the previous promoter exchange (Betz et al., 1994;kb upstream of the DQ52 element (Wood and Tonegawa,
Tumas-Brundage and Manser, 1997) and promoter du-1983). It is not known whether the Dsp2 element pos-
plication experiments (Peters and Storb, 1996), a slightsesses a promoter, orother promoter elements arepres-
reduction of the mutation frequency was observed withent between Dsp2 and DQ52. Since somatic hypermuta-
heterologous promoters. In these reports, the quantita-tion occurs preferentially in a 2 kb window downstream
tion of specific mRNA was determined in hybridomas,of a defined promoter (Lebecque and Gearhart, 1990;
but it is unknown whether mRNA levels of Ig genes inWeber et al., 1991; Rothenfluh et al., 1993; Rogerson,
these cells correlate with mRNA levels in GC B cells.1994; Peters and Storb, 1996), we speculate that the
Furthermore, it isdifficult to correlate transgene-specificremaining truncated DQ52 promoter fragment may pre-
mRNA and somatic hypermutation, because transgenesserve a low transcriptional activity in vivo, which would
tend to integrate at random in a concatemeric fashionimply that the rules for transcriptional regulation at the
into the genome, and often the RNA levels do not corre-DQ52 promoter as determined in vitro do not apply to
late with the copy number of the transgene.GC B cells analyzed ex vivo.
The latter problem not applying to the gene targeting
approach taken in this study, we compared the relativeThe RNA Polymerase I Promoter Allows
levels of RNA expressed from the mutant VHB1-8 genesSomatic Hypermutation
in GC B cells, taken ex vivo, using semiquantitative RT-When analyzing somatic hypermutation of the pol I pro-
moter-controlled VHB1-8 passenger gene, the mutation PCR. In contrast to non-GC-derived B cells, B cells of
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fragment containing the rDNA promoter-controlled VHB1-8 gene wasthe GC have more binding sites for the lectin peanut
subcloned into the SalI±ClaI sites of pIVhL2neor to generate the polagglutinin (PNA). Thus, GC B cells can be distinguished
I promoter (pI) construct.and sorted from other B cells using fluorescein-conju-
To generate the promoter deletion (pD) construct, a 0.7 kb NcoI±
gated PNA. In these cells, somatic hypermutation is EcoRI fragment of the VHB1-8 gene was subcloned into a NcoI±
known to be ongoing (Berek et al., 1991; Jacob et al., EcoRI site of pSL1190 vector (Pharmacia), released as a 0.7 kb
SalI±ClaI fragment, and subcloned further into the SalI±ClaI sites of1991). The relative frequency of somatic hypermutation
pIVhL2neor, which generates the pD construct.correlated well with the relative pre-mRNA level of the
One loxP site was inserted into the BalI±ClaI site of the JH2 intronpassenger transgenes found in CD45R1 PNAhigh B cells
of the VHB1-8 gene, and then a 2.0 kb XhoI±ClaI fragment wasisolated from the mutant strains. Since nonsense co-
subcloned into the SalI±ClaI sites of pIVhL2neor to generate the VH
dons can reduce the abundance of nuclear mRNA with- promoter (pII) construct.
out affecting the abundance of pre-mRNA or the half-
life of cytoplasmic mRNA (Cheng and Maquat, 1993; Generation of the Targeted ES Cells
NotI-linearized targeting vectors (30 mg) of each construct werePeltz et al., 1994; Maquat, 1995), the relatively high
transfected by electroporation into 1 3 107 E14.1 ES cells, respec-VHB1-8 pre-mRNA levels may be due to the presence
tively (KuÈhn et al., 1991). The transfected cells were selected withof a termination codon in the leader exons in the various
G418 (350 mg/ml) and gancyclovir (2 mM). Double resistant colonies
VHB1-8 transgenes, resulting in a rapid degradation of were screened by PCRusing a 59 primer (59-ACGATTACTACGGTAG
the corresponding mRNA species. Alternatively, a non- TAGCTAC-39) located at the DFL16.2 element in VHB1-8 and a 39
sense codon was found to inhibit RNA splicing in a B primer (59-GGAAACTAGAACTACTCAAGCTA-39) located 61 bp 39 of
the EcoRI site and 59 of the Em enhancer (Taki et al., 1993). PCRcell hybridoma (Lozano et al., 1994; Aoufouchi et al.,
amplification was performed for 40 cycles; each cycle consisted of1996). The mechanism for this translation independent
1 min at 958C, 1 min at 618C, and 2 min at 728C. Homologousmechanism remains unclear.
recombinant transfectants, positive for a 1.3 kb amplified fragment,
According to previous findings, the 59 boundary for were further verified by Southern blot analysis. Genomic DNA from
somatic hypermutation is located at or near the tran- PCR-positive colonies was EcoRI digested and hybridized with
scription start site, suggesting a linkage between tran- probe A (Figure 1A). Homologous recombinants were identified by
a 6.5 kb band corresponding to the wild-type allele and an additionalscription and somatic hypermutation (Lebecque and
1.9 kb band in the case of the pol I promoter (pI) targeted allele, orGearhart, 1990; Weber et al., 1991; Rothenfluh et al.,
an additional 1.8 kb band in the case of the promoter deletion1993; Rogerson, 1994; Peters and Storb, 1996). Further-
targeted allele, or an additional 1.2 kb band in the case of the VH
more, in case of the k light chain gene, the k intronic and promoter (pII) targeted allele. Out of 96 G418 and gancyclovir double
39 enhancers are critical cis-elements for hypermutation resistant clones of each targeted ES cell, two carried the targeted
(Betz et al., 1994; Yelamos et al., 1995). The results allele, in the case of the pI construct and the pD construct, and one
carried the targeted allele, in the case of the pol II construct.presented in this report indicate that somatic hypermu-
tation correlates with the transcriptional activity in the
Generation of the Mutant MiceIgH locus. This result is expected, if the transcription
For each construct, recombinant ES cell clones were injected intomachinery is physically associated with (part of) the
C57BL/6-derived blastocysts and transplanted into uteri of F1
hypermutator (Peters and Storb, 1996; Goyenechea et (BALB/c X C57BL/6) foster mothers. Chimeric mice were mated to
al., 1997). We had hoped to support this model by the C57BL/6 or the deleter strain (Schwenk et al., 1995) of C57BL/6
demonstration that hypermutation is only seen in the background. Offspring generated through germline transmission of
the ES cell genome, as indicated by coat color, were analyzed bycase of pol II± and not pol I±dependent transcription.
PCR on tail DNA, prepared as described by Laird et al. (1991) inIts occurrence in both cases, and the ambiguity of that
combination with the same primer set used for the screening ofresult makes us unable to exclude the possibility that
homologous recombinant ES cells. Mice carrying the targeted allele
the apparent correlation of somatic hypermutation with were confirmed by Southern blot analysis. Nonimmunized neor
the pre-mRNA levels might simply reflect the accessibil- gene-deleted heterozygous mice were analyzed at the age of 8±12
ity of the putative mutator to the IgH locus. weeks for the single-cell sorting and subsequent analysis of somatic
hypermutation. For the isolation of RNA, each mutant mouse was
immunized with 100 mg NP-CG alumn in 200 ml PBS 10 days beforeExperimental Procedures
analysis. Mice are kept under ordinary laboratory conditions.
Construction of the Targeting Vectors
The targeting vector pIVhL2neor was constructed as described (So- Cell Separation and Flow Cytometry
Single-cell suspensions from spleen were prepared by gently teas-noda et al., 1997). This vector was used as a targeting cassette
vector to introduce the modified B1-8 VHDHJH (VHB1-8) gene. ing the cells from the splenic capsule in medium (Dulbecco's modi-
fied Eagle's medium [DMEM] supplemented with 5% fetal calf se-A VHB1-8 gene with its VH promoter was cloned into the HincII site
of pBluescriptII vector (Stratagene), and the VH internal heptamer rum). They were treated with Tris-buffered 0.155 M NH4Cl for 5
min to remove erythrocytes and washed by centrifugation throughwas modified as described (Sonoda et al., 1997). To make this
VHB1-8 gene a passenger transgene, TGT/ATC at codon 215 and phosphate-buffered saline containing 1% bovine serum albumin
and 0.1% NaN3 (PBS, BSA, and NaN3). The splenic cells were stained214 (numbering according to Kabat and Wu, 1991) was modified
to TGA/CTC through site-directed mutagenesis. with a combination of rat anti-mouse IgM anti-CD5 (53-7.3; Ledbet-
ter and Herzenberg, 1979), and anti-Mac1 (M1/70.15.11; SpringerThe plasmid DNA pUC-SP/SalI, which contains mouse rDNA pro-
moter and enhancer of pMrE-SP (Kuhn et al., 1990), was kindly et al., 1979) antibodies coupled to magnetic beads (Miltenyi Biotech)
to deplete the IgM1 cells, T cells, and macrophage fractions byprovided by Dr. Ingrid Grummt (German Cancer Research Center,
Heidelberg, Germany). A 2.2 kb HindIII±EcoRI fragment of this vector using the MACS system (Miltenyi et al., 1990). The cells passing
through the column in the magnetic field were collected and furtherwas subcloned into HindIII±EcoRI sites of pBluescriptII vector (Stra-
tagene), and then a 2.2 kb XhoI±BamHI fragment was subcloned stained by a combination of fluorescein isothiocyanate (FITC)-conju-
gated R33-24-12 (anti-m; GruÈ tzmann, 1981), FITC-conjugated 1.3-5into a XhoI±BamHI site of pSL1190 vector (Pharmacia). A 1.3 kb
XhoI±NcoI VH promoter fragment upstream of the VHB1-8 gene was (anti-d; Roes et al., 1995), FITC-conjugated G7 (anti-Thy1; Gunter
et al., 1984), FITC-conjugated M1/70.15.11 (anti-Mac1; Springer etreplaced by a 2.2 kb XhoI±NcoI fragment of the rDNA promoter
from the above pSL1190 vector. Subsequently, a 2.9 kb XhoI±ClaI al., 1979), phycoerythrin (PE)-conjugated LS136 (anti-l; Reth et
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al., 1979), and allophycocyanin (APC)-conjugated RA3-6B2 (anti- 1987). Total cellular RNA was hybridized to random hexamer or
CD45R/B220; Coffman, 1982) in staining medium. By using a dual oligo(dT) primer (Boehringer Mannheim). First-strand cDNA synthe-
laser flow cytometer (FACStar Plus, Becton-Dickinson), FITC-nega- sis was performed using SuperScript II Reverse Transcriptase
tive, PE-positive, and APC-positive single cells were directly sorted (GIBCO-BRL). Two cDNA mixtures were prepared from each mutant
into 0.5 ml microtubes containing 20 ml PCR buffer (GIBCO-BRL, strain.
with 2.5 mM MgCl2) supplemented with 1 mg/ml 5S-ribosomal RNA
from Escherichia coli. Cells present in the lymphocyte gate (FoÈ rster Comparative RT-PCR
et al., 1989) were analyzed, while the dead cells were excluded from Comparative RT-PCR of cDNA mixtures was done as described
analysis by staining with propidium iodide. (Klein et al., 1997) with brief modifications. One-twentieth of each
For the isolation of RNA from the splenic cells, they were stained first-strand cDNA mixture, corresponding to about 5000 cell equiva-
with RA3-6B2 (anti-CD45R/B220; Coffman, 1982) coupled to mag- lent, was amplified using the 59 leader exon 1 primer and the VHB1-8
netic beads (Miltenyi Biotech), followed by magnetic cell sorting as exon primer [59-GCTTCAACCCAGTGCATCCA-39]. In separate PCR
described above. The cells attached to the column in the magnetic reactions, one-twentieth of a cDNA mixture was amplified using 59
field were collected and further stained by a combination of FITC- b-actin primer [59-GCACCACAACCTTCTACAATGAGCTG-39] and 39
conjugated PNA (Rose et al., 1980) and PE-conjugated RA3-6B2
b-actin primer [59-CACGCTCGGTCAGGATCTTCATGAG-39]. PCR
(anti-CD45R/B220; Coffman, 1982). By using a dual laser flow cyto- consists of 20 cycles (1 min at 958C, 1 min at 638C, and 1 min at
meter (FACStar Plus, Becton-Dickinson), 1 3 105 cells of B2201 728C) for the amplification of VHB1-8 cDNA, and 18 cycles for thePNAhigh fraction from each mutant strain were collected in 1.5-ml amplification of b-actin cDNA with the same PCR condition.
Eppendorf tubes. At least two tubes were prepared from each mu-
One-fifth of each PCR product was loaded onto a 2% agarose
tant mouse. gel. After gel-electrophoresis, PCR products were transferred to a
Nylon membrane according to standard procedures (Sambrook et
Single-Cell PCR
al., 1989). Membranes were hybridized with a32P-labeled PCR prod-
To prepare DNA for amplification, microtubes with single-cells were
ucts. For the generation of DNA probe, one-twentieth of first-strandoverlaid with mineral oil, 1 ml proteinase K (10 mg/ml; Boehringer)
cDNA from the pII mice was amplified with the 59 leader exon 1was added, and the samples were digested for 1 hr at 558C. The
primer/VHB1-8 exon 2 primer or the 59 b-actin primer/39 b-actin-2proteinase K was subsequently inactivated for 10 min at 958C. PCR
primer for 30 cycles under the conditions described above. PCRamplification was carried out in two rounds. The first reaction con-
products were cut from preparative 2% agarose gels, and the DNAtained two sets of primers: for the amplification of VHB1-8, 59 leader
was isolated using Spin-X columns (Costar). DNA was labeled withexon 1 primer [59-CACCATGGGATGGAGCTGAC-39] and 39 JC intron
a32P dATP using random primer according to standard procedure1 primer [59-CTCTGAAATCGATACCGTCG-39] were used for the pD
(Sambrook et al., 1989). After hybridization with the labeled PCRand the pI mice, and the same 59 leader exon primer and 39 JC
products, final washing of the corresponding membrane was per-intron 2 primer [59-TATGATCGGAATTCCTGCAG-39] were used for
formed with 0.1 3 SSC/0.1% sodium dodecyl sulfate at 608C. Densi-the pII mice. These primers hybridize specifically to the correspond-
tometric analysis of membranes for quantitation of band intensitiesing sequences in the inserted VHB1-8 of the targeted allele. The 59
was performed using a phosphoimager (Fuji, Tokyo, Japan).primers recognize the termination codon in the leader exon of the
VHB1-8 gene, and the 39 primers recognize the sequence of plasmid
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